SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: kennbill who wrote (1710)2/12/1999 4:03:00 PM
From: Stephen O  Respond to of 2135
 
Everyone take a look at IGT Pharma , IGT on VSE. Before you all ridicule this, remember QLT. Both QLT and IGT have the same antecedents, the University of British Columbia. QLT is now a $57 stock on TSE.
IGT has its anti cancer drug, AVLB, starting Phase 1 clinical trials at Roswell Park Cancer Center in Buffalo. Their research with mice ended 2 years ago. Real humans will be receiving AVLB. Yet market cap igf IGT is a mserable $7 million Cdn. They have a website

www.igtpharma.com